Assessment of Amikacin- and Capreomycin-Related Adverse Drug Reactions in Patients with Multidrug-Resistant Tuberculosis and Exploring the Role of Genetic Factors.

Freimane, Lauma; Barkane, Linda; Kivrane, Agnija; Sadovska, Darja; Ulanova, Viktorija; Ranka, Renate

Freimane, Lauma; Barkane, Linda; Kivrane, Agnija; Sadovska, Darja; Ulanova, Viktorija; Ranka, Renate.

Afiliação

Freimane L; Faculty of Pharmacy, Riga Stradins University, Dzirciema Street 16, LV-1007 Riga, Latvia.
Barkane L; Latvian Biomedical Research and Study Centre, Ratsupites Street 1, k-1, LV-1067 Riga, Latvia.
Kivrane A; Tuberculosis and Lung Diseases Center, Riga East Clinical University Hospital, LV-1038 Riga, Latvia.
Sadovska D; Faculty of Pharmacy, Riga Stradins University, Dzirciema Street 16, LV-1007 Riga, Latvia.
Ulanova V; Latvian Biomedical Research and Study Centre, Ratsupites Street 1, k-1, LV-1067 Riga, Latvia.
Ranka R; Faculty of Pharmacy, Riga Stradins University, Dzirciema Street 16, LV-1007 Riga, Latvia.

J Pers Med ; 13(4)2023 Mar 29.

Article em En | MEDLINE | ID: mdl-37108985

Palavras-chave

MDR-TB; amikacin; capreomycin; nephrotoxicity; ototoxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Pers Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google